RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Dipeptidyl peptidase 4 (DPP-4) inhibitors and the risk of lung cancer: current evidence and future directions.

Dipeptidyl peptidase 4 (DPP-4) inhibitors and the risk of lung cancer: current evidence and future directions.

Add to Collection
2023 Jan Others Fist_Author_Year_PM

Full Author : ['Singh, Harmanjit', 'Sharma, Jatin', 'Sikarwar, Pallavi', 'Kakkar, Ashish Kumar']
Journal Title : Expert review of clinical pharmacology
Chapter : Section3
Journal Year : 2023
Cited by : Not Available

INTRODUCTION: Recent evidence has linked long-term use of angiotensin converting enzyme (ACE) inhibitors with the risk of developing lung cancer by increasing levels of substance P (SP) and bradykinin in lung tissue. DPP-4 inhibitors, by virtue of their m.....

Keywords : ["lung cancer current evidence", "dipeptidyl peptidase inhibitor", "future direction", "risk"]